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Adriamycin, aquinone, inhibits succinic oxidase and 
NADH oxidase in mitochondria from cardiac muscle 
and in recent studies important findings are that this 
inhibition is reversed by UQ10, the naturally occur- 
ring homologue in heart mitochondria, nd that UQ10 
had some clinically beneficial effects when the anti- 
tumour drugs of the adriamycin family are used. The 
clinical work is apparently still in its early stages. 
Administration of UQ to rats decreases aldosterone 
formation and also inhibits the biological effects of 
aldosterone by combining with the receptor for 
aldosterone in the kidney tubular cells. Other bene- 
ficial effects of UQ reported includes increased resis- 
tance in rats and, shared with vitamin E and vitamin K, 
enhanced humoral immune responses although it has 
little effect on progressive muscular dystrophy. 
The participants in this Congress were, in the main, 
committed to the view that ubiquinone is a vitamin. 
It could have been scientifically more satisfying if the 
view of those who have some doubts about his con- 
cept had also been heard. For biochemists a critical 
assessment of some of the important clinical reports 
would have been very useful, particularly if some of 
the simpler queries which went through one's mind 
were explained, such as why in some experiments was 
UQ injected and in others given by mouth? or does 
orally administered UQ reach the site of action 
unchanged? 
The book is well produced by a photo-offset pro- 
cess and merits careful reading by all scientists inter- 
ested in the development of rational biochemical 
treatment for pathological conditions. 
T. W. Goodwin 
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Studies over the past three decades have provided 
detailed insight into the molecular basis for the bio- 
logical action of most of the water-soluble vitamins 
and in recent years also for certain of the fat-soluble 
vitamins notably vitamins D and K. Indeed once the 
relationship between epithelial growth and vitamin A 
is elucidated a fairly complete picture will exist for 
all but two of the diverse group of accessory food 
factors which are arbitrarily classified as vitamins. For 
the two remaining vitamins (C and E) no clear pic- 
ture is yet apparent and for both of them, but notably 
for vitamin C, recent developments have confused 
rather than clarified the situation. Following Pauling's 
proposal in 1970 that pharmacological doses of vita- 
min C could protect against, and inhibit the develop-.. 
ment of the common cold, a very considerable amount 
of effort has been directed to clinical assessment of 
the validity of this regimen. The results of such studies 
are largely inconclusive since, although the statistical 
evidence fails to support Pauling's hypothesis, the 
uncertainties surrounding the definition of the clinical 
features of the condition leave much room for doubt 
in respect o the basis for analysis of the clinical obser- 
vations. In this context one is tempted to give at least 
some credence to the many individuals who are con- 
vinced that Pauling's regignen does indeed diminish 
their susceptibility o such infection. 
Dr Lewin makes it clear in the preface to his mono- 
graph that he belongs to the school which believes in 
efficacy of the pharmacological dose regimen - both 
for the common cold and other conditions uch as 
anginal pain and atherosclerosis which may not have 
fallen within the scope of the original concept. Since 
as with other 'believers' the basic premise is not in 
question the monograph is devoted to the production 
of evidence in favour of the initial postulate and can 
in no sense be regarded as a balanced treatment of the 
subject. Dr Lewin does make valid points in regard to the 
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questions of placebos; and of factors influencing ascor- 
bate absorption in the clinical trials which have failed 
to demonstrate a significant effect of ascorbate. How- 
ever one comes, in the end, back to the critical ques- 
tion of specificity of effect which bedevils the assess- 
ment of most of the reported effects of both vitamins 
C and E. While ascorbate can be shown to serve as an 
electron acceptor for many reactions in vitro it is 
almost always possibel to use other acceptors of 
similar redox potential. In this situation a guide to 
in vivo reality may be provided by a careful analysis 
of the symptoms of deficiency although as illustrated 
by many of the B vitamins there is no assurance of 
enlightenment even from this approach. At all events 
an attempt o apply such an evaluation leads only to 
other questions. For example what is the 'normal' 
state in respect o the virus infections and other con- 
ditions which are supposed to be diminished or prevent- 
ed by ascorbate? Is there really any solid evidence that 
modern man is subjected to a higher level of bioche- 
mical stress which can be ameliorated by the high 
dose regimen as claimed here? It is not easy to see how 
one can best proceed to answer these and other simi- 
lar questions but I am not convinced that the field is 
helped by the uncritical approach adopted by Dr Lewin 
in relating the in vitro and in vivo observations. 
If one disregards the polemical aspects the book is 
useful in bringing together amass of literature on the 
various aspects of vitamin C and will have some value 
as a reference source. The utility in this respect is 
however diminished by numerous mistakes and incom- 
plete references in the bibliography. In all I see no 
particular eason to recommend it except as an addi- 
tional source of material for those who believe in the 
mega-dose regime and are seeking bases on which to 
support heir prejudice. 
M. C. Scrutton 
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Purine metabolism together with its regulation and 
disorders has been a continuing area of interest for 
biochemists and clinicians over many years. The attrac- 
tions of this area of investigation has increased recently 
due to two major developments. Firstly, it has been 
shown that lesions in purine metabolism can in some 
instances be associated with immunodeficiency dis- 
orders and may possibly be the cause of some of these 
diseases. Secondly there is increasing recognition of 
the role of certain purines in intercellular communica- 
tion. These developments have in turn focused atten- 
tion on purine metabolism and its regulation which is 
far from completely understood in mammalian 
systems; especially in respect o tissue interactions, 
and to the relationship between exogeneous purine 
and pyrimidine supply and the rate of the novo syn- 
thesis of these metabolites in vivo. Thus the sympo- 
sium is timely from many points of view and has 
brought ogether workers from a wide range of dis- 
ciplines and interests. As might be expected there is 
considerable discussion, both biochemical and clinical, 
of the Lesch-Nyhan syndrome (Nyhan and McKeyan), 
and also of the use of cultured cells derived from 
Lesch-Nyhan patients to probe the relationship of the 
de novo and salvage pathways of purine nucleotide 
synthesis with special reference to the possible regula- 
tory role of phosphoribosylpyrophosphate concentra- 
tion (Reem). Further evidence for an important role 
for this metabolite is provided by studies on a gouty 
family in whom there is elevated activity of phos- 
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